TEM Tempus: Expected earnings per share growth for next year
Tempus AI, Inc (TEM) possesses exclusive medical data archives for which the largest pharmaceutical companies pay for access. The promising growth trajectory for EPS estimates shows a reversal driven by AI-powered genetic analysis for tumor therapy and the rapid commercial success of its personalized treatment platform. The value of 70.10 represents the current metric, capturing analysts' real-time earnings expectations.
Analytical breakdowns for Tempus AI, Inc
- share price and consensus valuation forecast:
- company stock capitalization data:
- book capitalization information:
- company total debt and liquidity indicators:
- earnings and valuation multiples information:
TEM - Company Profit|Expected Profit Tempus AI, Inc|TEM - Price to Earnings Multiple|Forward P/E Multiple Tempus Labs|TEM - PEG Multiple|Enterprise Value to EBITDA Ratio Tempus|TEM - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Tempus|TEM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months tempus.com|TEM - Net earnings per share growth this year|Net earnings per share growth forecast for next year Tempus AI, Inc
Fundamental valuation:Tempus AI Inc, TEM
This indicator reflects the analysts' consensus forecast for earnings per share changes, measuring the scaling rates of net income. By analyzing EPS growth prospects for the next fiscal year, investors assess the readiness of pharma behemoths to monetize AI genomic testing data. The trend line confirms the effectiveness of integrating personalized medicine into the Tempus AI (TEM) business model. The uniqueness of the oncology data base ensures the stability of these expectations, minimizing the risks of a fundamental revaluation.
Competitors of Tempus AI, Inc
QGEN (Qiagen Group) - Earnings growth forecast for next year|Isis Pharmaceuticals (IONS) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year RGEN (Repligen Corporation)|RNA (aviditybiosciences.com) - Expected earnings per share trend next year|Earnings growth forecast for next year CRSP (CRISPR Therapeutics)|Consensus forecast of earnings per share growth for next year GeneDx Holdings (WGS)|RARE - Net earnings per share growth forecast for next year|BEAM (Beam Tx) - Projected earnings per share growth rate for next year|SRPT: Earnings growth forecast for next year|Expected earnings per share growth for next year twistbioscience.com|Expected earnings per share growth for next year TXG|NTLA (Intellia Therapeutics Inc) - Projected earnings per share increase next year|Earnings growth forecast for next year STOK|BLFS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Wave Life Sciences WVE|MAZE - Expected earnings per share growth for next year|Sionna Therapeutics - Earnings growth forecast for next year|PRME (Prime Medicine Inc) - Projected earnings per share growth rate for next year|Taysha (TSHA) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year QURE|MGTX (MeiraGTx Holdings plc) - Earnings growth forecast for next year|Earnings growth forecast for next year regenxbio.com|Expected earnings per share growth for next year SLDB (Solid Biosciences)|Projected earnings per share increase next year OCGN|Earnings growth forecast for next year PACB (Pacific Biosciences of California)|Benitec Corp (BNTC) - Expected net earnings per share growth next year|DSGN - Net earnings per share growth forecast for next year|rocketpharma.com (RCKT) - Expected earnings per share growth for next year|4D Molecular Therapeutics, Inc. (FDMT) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year LXEO (Lexeo Therapeutics, Inc.)|Expected earnings per share growth for next year KRRO|Earnings growth forecast for next year Editas Corp|Net earnings per share growth forecast for next year Silence Therapeutics (SLN)|Consensus forecast of earnings per share growth for next year proqr.com|Codexis - Expected earnings per share growth for next year|Expected earnings per share trend next year SGMO|Nautilus Biotechnology Inc - Earnings growth forecast for next year|MGX - Earnings growth forecast for next year|DTIL: Earnings growth forecast for next year|GBIO - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year BOLD|XCUR: Expected earnings per share trend next year|Earnings growth forecast for next year IMNN|Consensus forecast of earnings per share growth for next year phiopharma.com|Net earnings per share growth forecast for next year Mustang Bio MBIO|RNAZ: Projected earnings per share growth rate for next year|Bionano - Earnings growth forecast for next year|Applied DNA Sciences Inc (APDN) - Expected earnings per share growth for next year|BLUE (Bluebird Bio) - Expected earnings per share growth for next year|IPA: Projected earnings per share increase next year|OMGA (Omega Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year singulargenomics.com OMIC|Net earnings per share growth forecast for next year Regulus Therapeutics Inc. (RGLS)|Expected earnings per share growth for next year Syros Pharmaceuticals Inc. SYRS|Earnings growth forecast for next year TBIO (Codex DNA)|TCON: Projected earnings per share growth rate for next year|UBX - Net earnings per share growth forecast for next year
